1. Home
  2. TY vs INVA Comparison

TY vs INVA Comparison

Compare TY & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tri Continental Corporation

TY

Tri Continental Corporation

HOLD

Current Price

$33.07

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Innoviva Inc.

INVA

Innoviva Inc.

HOLD

Current Price

$19.57

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TY
INVA
Founded
1929
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
TY
INVA
Price
$33.07
$19.57
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$36.80
AVG Volume (30 Days)
43.0K
959.7K
Earning Date
01-01-0001
02-25-2026
Dividend Yield
3.36%
N/A
EPS Growth
N/A
53.96
EPS
4.78
1.52
Revenue
N/A
$388,521,000.00
Revenue This Year
N/A
$13.23
Revenue Next Year
N/A
$8.58
P/E Ratio
$6.38
$12.66
Revenue Growth
N/A
10.14
52 Week Low
$25.16
$16.52
52 Week High
$30.73
$22.76

Technical Indicators

Market Signals
Indicator
TY
INVA
Relative Strength Index (RSI) 48.28 41.38
Support Level $32.57 $19.26
Resistance Level $32.88 $20.23
Average True Range (ATR) 0.39 0.48
MACD 0.07 -0.05
Stochastic Oscillator 73.55 30.69

Price Performance

Historical Comparison
TY
INVA

About TY Tri Continental Corporation

Tri-Continental Corp is a United States-based closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Share on Social Networks: